ArticleHuman vaccines & immunotherapeutics2026
Acceptance of the respiratory syncytial virus infant monoclonal antibody nirsevimab among post-partum women in Italy.
Silvia Angelillo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.